These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 3120274

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine.
    Cryz SJ, Fürer E, Que JU.
    Infect Immun; 1991 Jan; 59(1):45-50. PubMed ID: 1898901
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans.
    Cryz SJ, Cross AS, Sadoff JC, Wegmann A, Que JU, Fürer E.
    J Infect Dis; 1991 May; 163(5):1040-5. PubMed ID: 1708398
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A].
    Dmitriev BA, Kul'shin VA, Antsiferova NG, Vovk VA, Moroz AF.
    Dokl Akad Nauk SSSR; 1988 May; 298(5):1277-80. PubMed ID: 2454182
    [No Abstract] [Full Text] [Related]

  • 11. The novel multispecies Fc-specific Pseudomonas exotoxin A fusion protein α-Fc-ETA' enables screening of antibodies for immunotoxin development.
    Klausz K, Kellner C, Derer S, Valerius T, Staudinger M, Burger R, Gramatzki M, Peipp M.
    J Immunol Methods; 2015 Mar; 418():75-83. PubMed ID: 25701195
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.
    Fattom A, Schneerson R, Szu SC, Vann WF, Shiloach J, Karakawa WW, Robbins JB.
    Infect Immun; 1990 Jul; 58(7):2367-74. PubMed ID: 2114365
    [Abstract] [Full Text] [Related]

  • 13. Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.
    Cryz SJ, Fürer E, Cross AS, Wegmann A, Germanier R, Sadoff JC.
    J Clin Invest; 1987 Jul; 80(1):51-6. PubMed ID: 3110215
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines.
    Konadu E, Robbins JB, Shiloach J, Bryla DA, Szu SC.
    Infect Immun; 1994 Nov; 62(11):5048-54. PubMed ID: 7927787
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunogenicity of tetanus toxoid conjugates of anti-idiotypes that mimic Pseudomonas aeruginosa surface polysaccharides.
    Schreiber JR, Dahlhauser P.
    Infect Immun; 1994 Jan; 62(1):308-12. PubMed ID: 8262644
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ, Lang A, Rüdeberg A, Wedgwood J, Que JU, Fürer E, Schaad U.
    Behring Inst Mitt; 1997 Feb; (98):345-9. PubMed ID: 9382759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.